Aileron Therapeutics Inc (NASDAQ:ALRN)

3.17
Delayed Data
As of Jan 23
 0.00 / 0.00%
Today’s Change
1.79
Today|||52-Week Range
15.00
+33.76%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2015

2016

2017

2018
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization325.0K232.0K95.0K218.0K
 
 
 
 
 
 
Operating ExpensesGross Income-325.0K-232.0K-95.0K-218.0K
 
 
 
 
 
General Expenses12.6M17.9M22.9M31.7M
 
 
 
 
 
Research And Development7.8M10.3M14.2M18.4M
 
 
 
 
 
Total Operating Expenses12.9M18.2M23.0M31.9M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-12.9M-18.2M-23.0M-31.9M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-12.9M-18.1M-22.6M-31.5M
 
 
 
 
 
Preferred Dividend-71.0K-75.0K-41.0K0.00
 
 
 
 
Net Income-12.9M-18.1M-22.6M-31.5M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS14.7M14.7M7.4M14.7M
 
 
 
 
 
Shares To Calculate EPS Diluted14.7M14.7M7.4M14.7M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.88-$1.91-$3.04-$2.14
 
 
 
 
 
EPS Diluted-$0.88-$1.24-$3.04-$2.14